Research Classification AOD-9604 is classified in research literature as a growth hormone fragment peptide, distinct from GHRH analogs, GLP-1 receptor agonists, and full-length growth hormone itself
"When nutrients especially fats, proteins, and soluble fibers interact with these [L-cells], they stimulate GLP-1 release." Patricia Bannan, Registered Dietitian Additionally, the fiber in both oats and quinoa can help combat constipation, a common side effect of GLP-1 therapy
When fat is lost quickly, estrogen levels may drop slightly, which can lead to dryness and thinning of the tissues, similar to mild menopausal-like changes, even in younger women
Both are legal sources for compounded semaglutide, but 503B facilities generally have more rigorous quality controls